(Q40247245)

18 September 2017

title

Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry (English)

1 reference

18 September 2017

1 reference

Johnan A R Kaleeba

1

1 reference

18 September 2017

Edward A Berger

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

2 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

354

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

7-14

1 reference

Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Human herpesvirus 8 interaction with target cells involves heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Virus attachment and entry offer numerous targets for antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Pathogenesis of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: early events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Pseudorabies virus glycoprotein M inhibits membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Cell surface heparan sulfate and its roles in assisting viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Roles for Endocytosis and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

CD46 is a cellular receptor for human herpesvirus 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Herpesvirus entry: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Virion proteins of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.06.009

1 reference

18 September 2017

1 reference